Does continuous learning fuel our drive, our dedication, and, perhaps, our dreams?

Catch up on the top radiology content of the past week.

Offering an array of AI-powered automation and image optimization, the new Elevate software is geared to maximizing workflow efficiencies for the EPIQ Elite and Affiniti ultrasound systems.

For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.

18F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.

Enabling up to 80 percent faster MRI scan times, the SubtleHD software is included in the newly launched AI software suite Subtle-Elite.

Reviewing current and emerging trends in imaging utilization and the impact of attrition rates and radiology residency positions on the field, researchers explore the future of radiology with two new provocative studies.

New research shows that premenopausal status, lactation, and hormone replacement therapy (HRT) all lead to higher background parenchymal enhancement grades on contrast-enhanced mammography.

Preoperative use of the scoring system for gadoxetic acid-enhanced MRI demonstrated an average AUC of 85 percent and average specificity of 89 percent in external validation cohorts for pathologic features of hepatocellular carcinoma.

A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.

The advanced reconstruction algorithm offers optimal noise reduction, artifact correction, detailed spectral data and streamlined radiation dosing across cardiac, pulmonary and oncologic imaging.

Anterior tumor location was over 14 times more likely to be associated with axillary metastasis after neoadjuvant treatment for breast cancer, according to new breast MRI and ultrasound research.

Is there a certain amount of storytelling in diagnostic radiology?

Catch up on the top radiology content of the past week.

In a video interview from the International Stroke Conference (ISC), Jeremy Heit, M.D., Ph.D., discussed new research revealing over 90 percent sensitivity and specificity rates for AI detection of subdural hematomas on non-contrast-enhanced head CTs.

Phase 2 studies of the BR55 ultrasound contrast agent reportedly demonstrated a 95 percent accuracy in showing the expression of vascular endothelial growth factor receptor 2 (VEGFR2) in bowel segments reflecting active inflammation in patients with Crohn’s disease.

The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).

The PET/CT agent 18F-PSMA-1007 offered the highest surface under the cumulative ranking curve (SUCRA) out of nine radiotracers at the patient and lesion level for detecting clinically significant prostate cancer (csPCa), according to a meta-analysis.

Use of the mammography AI software had a nearly equivalent false positive rate as unassisted radiologist interpretation and resulted in a 44 percent reduction in screen reading workload, according to findings from a randomized controlled trial involving over 105,000 women.

Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.